NDA Group

NDA is a leading global regulatory affairs and drug
development consultancy with over 25 years of
experience in helping clients gain approval for their
medicines.With a portfolio of over 1600 clients
worldwide, we specialize in helping pharmaceutical and
biotech companies navigate the complex and everchanging
regulatory landscape in Europe, the US, and
the UK, with a focus on oncology, advanced therapies,
and rare diseases.Our exceptional track record speaks
for itself, as we have played a critical role in the
approval of a quarter of all new medicines in the US
and EU over the last 3 years.As a leading consultancy
in the industry, we provide unmatched regulatory
expertise and partner with our clients to optimize the
development of complex and innovative treatments
that meet the demanding standards of regulatory
agencies.